<DOC>
	<DOCNO>NCT00002273</DOCNO>
	<brief_summary>To attempt demonstrate efficacy ganciclovir ( DHPG ) treatment cytomegalovirus ( CMV ) colitis AIDS patient evaluate clinical virologic parameter . To determine acceptability safety profile 2-week course intravenous ( IV ) DHPG therapy .</brief_summary>
	<brief_title>A Study Ganciclovir Treatment Cytomegalovirus Large Intestine Patients With AIDS</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Ganciclovir</mesh_term>
	<mesh_term>Ganciclovir triphosphate</mesh_term>
	<criteria>Inclusion Criteria Patients must : An underlying diagnosis AIDS CDC surveillance definition ( group IV , category c1 subgroup D ) . Colitis manifest clinically diarrhea . Colon biopsy demonstrate typical histologic picture cytomegalovirus ( CMV ) disease . Cultures CMV blood urine obtain within 1 week study entry need positive prior entry . ( A positive culture need final inclusion AN . ) Prior Medication : Allowed : Topical acyclovir . Exclusion Criteria Coexisting Condition : Patients follow excluded : History chronic acute liver disease . History significant mental illness . Life expectancy &lt; 1 month . Presence cause colitis cytomegalovirus ( CMV ) . ( The following test must negative : Stool culture enteric bacterial pathogen , stool exam ovum parasite , stool exam cryptosporidia , stool exam AFB . ) Colitis severe would patient 's best interest treat placebo 2 week prior eligible receive ganciclovir ( DHPG ) `` compassionate '' use basis . Patients colitis severity treat DHPG `` compassionate '' use basis . Presence clinically significant extracolonic active CMV disease retina visceral organ ( could progress notreatment period ) . Presence significant renal disease result decrement creatinine clearance normal . Concurrent Medication : Excluded : Any investigational drug , whether part formal clinical study . Patients follow excluded : History chronic acute liver disease . History significant mental illness . Life expectancy &lt; 1 month . Presence cause colitis cytomegalovirus ( CMV ) . ( The following test must negative : Stool culture enteric bacterial pathogen , stool exam ovum parasite , stool exam cryptosporidia , stool exam AFB . ) Colitis severe would patient 's best interest treat placebo 2 week prior eligible receive ganciclovir ( DHPG ) `` compassionate '' use basis . Patients colitis severity treat DHPG `` compassionate '' use basis . Presence clinically significant extracolonic active CMV disease retina visceral organ ( could progress notreatment period ) . Presence significant renal disease result decrement creatinine clearance normal . Prior Medication : Excluded within 2 day study entry : Nucleoside analog . Excluded within 1 week study entry : Antimetabolites interferon .</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 1989</verification_date>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Ganciclovir</keyword>
	<keyword>Cytomegalovirus Infections</keyword>
	<keyword>Colitis</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
</DOC>